ClinicalTrials.Veeva

Menu

Ease of Use and Blood Clotting for the Gambro Polyflux HD-C4 Big Dialyzer

Baxter logo

Baxter

Status

Completed

Conditions

Chronic Kidney Failure

Study type

Observational

Funder types

Industry

Identifiers

NCT00659724
Gambro 1462

Details and patient eligibility

About

The purpose of this study is to collect information on the ease of use and thrombogenicity of the Polyflux HD-C4 Big and Fresenius Optiflux 180NR or 200NR dialyzers under conditions of routine clinical use for hemodialysis.

Full description

This ease of use study involves the use of FDA 510(k) cleared hemodialyzers and will have no impact on the patient's routine dialysis therapy. This study is aimed at obtaining feedback from the nursing and technical staff regarding the use and thrombogenicity of the Polyflux HD-C4 Big, and Fresenius Optiflux 180NR or 200NR dialyzers. The dialysis nursing staff will complete ease of use and thrombogenicity assessments following routine dialysis therapy. Any adverse events will be tracked for the study patients.

Enrollment

33 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Hemodialysis patients 18 years of age or older

Exclusion criteria

  • n/a

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems